Strontium ranelate

Strontium ranelate is an active ingredient that is used in some medicines.

The active ingredient is the chemical in a medicine that makes it work. Medicines can have more than one active ingredient and be available under different brand names. Medicines include both active ingredients and inactive ingredients.

This page about strontium ranelate automatically lists related information collected from other pages of our website.

The list below also includes links to brands of medicines that contain strontium ranelate, including their consumer medicine information (CMI) leaflets.

Consumers: If you have any questions about medicines, you can speak to one of our pharmacists at NPS Medicines Line by calling 1300 633 424. You can ring Monday to Friday, 9 am to 5 pm, Australian Eastern Standard Time (excluding NSW public holidays). For non-medicine products, further information may also be available from the manufacturer.

Related information - strontium ranelate


(Media release)
08 Aug 2016 As of 1 August 2016, the osteoporosis medicine strontium is no longer available on the Pharmaceutical Benefits Scheme (PBS).
(Consumer publication)
22 Jul 2016 Strontium ranelate (Protos), a prescription medicine used to treat severe osteoporosis, will be deleted from the PBS from 1 August 2016. Find out more.
For health professionals (Condition)
01 Oct 2015 Choose osteoporosis medicines based on clinical assessment of risk factors, absolute fracture risk and/or BMD measurement. Monitor for effectiveness and adherence.
22 Jan 2015 Protos Granules for oral suspension is a brand of medicine containing the active ingredient strontium ranelate. Find out about side effects, who can take it and who shouldn’t use Protos Granules for oral suspension by reading the latest Australian consumer medicine information, plus tips on how to use medicines wisely and safely.
For health professionals (Health professional publication)
03 Apr 2014 Following a TGA review, strontium ranelate should only be used in patients for whom other osteoporosis treatments are unsuitable. What else do health professionals need to know?
For health professionals (e-newsletter for health professionals)
18 Jul 2013 Diet & prostate cancer | Genetics tests in psychiatry | CT cancer risk for kids
For health professionals (Health professional publication)
20 Jun 2013 Strontium ranelate (Protos) increases the risk of myocardial infarction. Find out how to reduce risk in your patients with osteoporosis.
30 Nov 2012 Doxycycline can interact with Oral retinoids (isotretinoin or acitretin, used to treat acne and tretinoin used to treat leukaemia). Find out more about the interactions with doxycycline
For health professionals (Health professional publication)
23 Apr 2010 New information relevant to this topic has become available since this RADAR review was published in November 2007.
(Consumer publication)
01 Apr 2008 Information for consumers about strontium ranelate (Protos) for post-menopausal osteoporosis.

Medicine brands that contain strontium ranelate